HOME | CONTACT | SITEMAP
  • HOME
  • CORPORATE
    • VISION
    • MANAGEMENT TEAM
    • BOARD OF DIRECTORS
    • CLINICAL ADVISORY BOARD
    • SCIENTIFIC ADVISORY BOARD
    • CORPORATE GOVERNANCE
  • TECHNOLOGY
    • NTx®-265 (Stroke)
    • NTx®-428 (Brain Trauma)
    • NTx®-488 (Multiple Sclerosis)
    • PUBLICATIONS
    • MEDIA CENTRE
    • GLOSSARY
  • INVESTORS
    • STOCK INFORMATION
    • FINANCIAL REPORTS
    • STROKE MARKET
    • SHAREHOLDER SERVICES
    • INVESTOR CONTACT
  • NEWS & EVENTS
    • PRESS RELEASES
    • EVENTS
    • PRESENTATIONS
    • LINKS
  • TSX - Venture:  SSS

SITE MAP
Skip Navigation Links Skip Navigation Links.
HOME
Collapse CORPORATECORPORATE
VISION
MANAGEMENT TEAM
BOARD OF DIRECTORS
CLINICAL ADVISORY BOARD
SCIENTIFIC ADVISORY BOARD
CORPORATE GOVERNANCE
Collapse TECHNOLOGYTECHNOLOGY
NTx®-265 (Stroke)
NTx®-428 (Brain Trauma)
NTx®-488 (Multiple Sclerosis)
PUBLICATIONS
MEDIA CENTRE
GLOSSARY
Collapse INVESTORSINVESTORS
STOCK INFORMATION
FINANCIAL REPORTS
STROKE MARKET
SHAREHOLDER SERVICES
INVESTOR CONTACT
Collapse NEWS & EVENTSNEWS & EVENTS
PRESS RELEASES
EVENTS
PRESENTATIONS
LINKS
STOCK QUOTE
Symbol:
TSX:SSS
Last Trade: 0.275
Change: 0.00%
Volume: 87425
Date: 3/9/2010
Time: 3:59pm

Note: Quotes are delayed. For informational purposes only.

LETTER TO SHAREHOLDERS
+ 2008 Letter to Shareholders
FACT SHEET
©2004 - 2010 Stem Cell Therapeutics - All rights reserved
Home  |  Site Map  |  Terms Of Use |  Contact Us